ZOOK BRIAN D 4
4 · Liberty Latin America Ltd. · Filed Jul 17, 2026
Research Summary
AI-generated summary of this filing
Liberty Latin America (LILA) Brian Zook Receives Preferred Shares
What Happened Brian D. Zook (MD, Chief Accounting Officer) received Series A Preferred Shares as part of a special dividend declared May 21, 2026 and payable June 16, 2026. He directly received 4,918 Preferred Shares and an additional 140 Preferred Shares credited to his IRA (total 5,058 preferred shares). In addition, a derivative award (adjusted share appreciation rights/SARs) was reported on June 17, 2026 covering 2,164 shares (reported with $0 cash consideration). The dividend converted entitlement into newly issued 9.0% Fixed Rate Cumulative Perpetual Redeemable Series A Preferred Shares (ticker LILAP), initial liquidation price $25 per preferred share. These were recorded as "other acquisition or disposition (J)" — i.e., receipt via dividend, not an open-market purchase.
Key Details
- Transaction dates: June 16, 2026 (preferred shares received) and June 17, 2026 (derivative adjustment).
- Shares received: 4,918 preferred shares directly + 140 preferred shares in IRA = 5,058 preferred shares; derivative reported: 2,164 SAR-adjusted shares. Reported dollar amount: $0 (no cash paid/received).
- Reason: Special dividend of 0.10 Series A Preferred Shares per common share; SARs and other awards were adjusted under anti-dilution provisions due to the dividend (compensation committee approved under Rule 16b-3).
- Vesting/derivative notes: Some SARs and RSUs were adjusted with varying vesting schedules (some vest in full March 15, 2027; others vest in installments through 2029). One derivative security is noted as fully vested (see filing footnotes).
- Filing timeliness: Form 4 was filed July 17, 2026 covering mid-June transactions — approximately one month after the transactions (appears late); check the full Form 4 for explanations or amendments.
- Trading symbols: common shares LILA, LILAB, LILAK; Series A Preference Shares LILAP (per filing remarks).
Context This transaction is receipt of a corporate special dividend (preferred shares) and adjustments to equity awards — routine corporate actions and compensation-plan anti-dilution adjustments rather than an insider buying or selling common stock. Such dividend-issued securities and SAR adjustments are typically administrative and do not necessarily signal insider trading intent. For precise post-transaction holdings, valuation, or questions about timeliness, consult the full Form 4 (Accession 0001725076-26-000003).
Insider Transaction Report
Form 4
ZOOK BRIAN D
MD, CHIEF ACCOUNTING OFFICER
Transactions
- Other
Series A Preference Shares
[F1]2026-06-16+4,918→ 4,918 total - Other
Series A Preference Shares
[F2]2026-06-16+140→ 140 total(indirect: By IRA) - Other
Restricted Share Units P
[F3][F4]2026-06-17+2,164→ 2,164 total→ Series A Preference Shares (2,164 underlying)
Holdings
- 15,170
Share Appreciation Rights A
[F5][F6]Exercise: $13.03Exp: 2028-05-01→ Class A Common Shares (15,170 underlying) - 31,190
Share Appreciation Rights C
[F5][F7]Exercise: $12.41Exp: 2028-05-01→ Class C Common Shares (31,190 underlying) - 14,847
Share Appreciation Rights A
[F5][F8]Exercise: $13.93Exp: 2029-05-01→ Class A Common Shares (14,847 underlying) - 30,526
Share Appreciation Rights C
[F5][F9]Exercise: $13.63Exp: 2029-05-01→ Class C Common Shares (30,526 underlying) - 26,709
Share Appreciation Rights A
[F5][F10]Exercise: $7.29Exp: 2030-03-16→ Class A Common Shares (26,709 underlying) - 54,913
Share Appreciation Rights C
[F5][F11]Exercise: $7.13Exp: 2030-03-16→ Class C Common Shares (54,913 underlying) - 47,666
Share Appreciation Rights A
[F5][F12]Exercise: $9.80Exp: 2031-03-16→ Class A Common Shares (47,666 underlying) - 98,000
Share Appreciation Rights C
[F5][F13]Exercise: $9.60Exp: 2031-03-16→ Class C Common Shares (98,000 underlying) - 23,699
Share Appreciation Rights A
[F5][F14]Exercise: $9.80Exp: 2031-03-16→ Class A Common Shares (23,699 underlying) - 48,724
Share Appreciation Rights C
[F5][F15]Exercise: $9.60Exp: 2031-03-16→ Class C Common Shares (48,724 underlying) - 36,386
Share Appreciation Rights A
[F5][F16]Exercise: $6.78Exp: 2032-03-11→ Class A Common Shares (36,386 underlying) - 74,808
Share Appreciation Rights C
[F5][F17]Exercise: $6.56Exp: 2032-03-11→ Class C Common Shares (74,808 underlying) - 23,626
Share Appreciation Rights A
[F5][F18]Exercise: $5.47Exp: 2033-03-20→ Class A Common Shares (23,626 underlying) - 48,574
Share Appreciation Rights C
[F5][F19]Exercise: $5.30Exp: 2033-03-20→ Class C Common Shares (48,574 underlying) - 29,303
Share Appreciation Rights A
[F20][F21]Exercise: $4.31Exp: 2034-03-12→ Class A Common Shares (29,303 underlying) - 60,246
Share Appreciation Rights C
[F20][F22]Exercise: $4.24Exp: 2034-03-12→ Class C Common Shares (60,246 underlying) - 27,082
Share Appreciation Rights A
[F23][F24]Exercise: $4.68Exp: 2035-03-14→ Class A Common Shares (27,082 underlying) - 55,682
Share Appreciation Rights C
[F23][F25]Exercise: $4.54Exp: 2035-03-14→ Class C Common Shares (55,682 underlying) - 23,978
Share Appreciation Rights A
[F26][F27]Exercise: $5.31Exp: 2036-03-13→ Class A Common Shares (23,978 underlying) - 49,297
Share Appreciation Rights C
[F26][F28]Exercise: $5.29Exp: 2036-03-13→ Class C Common Shares (49,297 underlying)
Footnotes (28)
- [F1]On May 21, 2026, the Issuer announced that an authorized committee of the Issuer's board of directors declared a special dividend on each of its outstanding common shares payable on June 16, 2026 to all holders of record as of 5:00 p.m., New York City time, on June 1, 2026 consisting of a special dividend of 0.10 shares of newly issued 9.0% Fixed Rate Cumulative Perpetual Redeemable Series A Preferred Shares (the "Preferred Shares"), having an initial liquidation price of $25 per Preferred Share (the "Dividend"). As a result of the Dividend, the reporting person directly received 4,918 Preferred Shares.
- [F10]This SAR was previously reported as a SAR relating to 18,678 shares of the Issuer's common stock at a base price of $10.42 and was adjusted as a result of the Dividend. In connection with the Dividend, all SARs held by the reporting person with respect to the Issuer's common stock were adjusted pursuant to the anti-dilution provisions of the incentive plan under which such award was granted, such that the number of shares subject to, and the base price of, such SAR were adjusted. These adjustments were approved by the compensation committee of the Issuer's board of directors pursuant to Rule 16b-3.
- [F11]This SAR was previously reported as a SAR relating to 37,356 shares of the Issuer's common stock at a base price of $10.48 and was adjusted as a result of the Dividend. In connection with the Dividend, all SARs held by the reporting person with respect to the Issuer's common stock were adjusted pursuant to the anti-dilution provisions of the incentive plan under which such award was granted, such that the number of shares subject to, and the base price of, such SAR were adjusted. These adjustments were approved by the compensation committee of the Issuer's board of directors pursuant to Rule 16b-3.
- [F12]This SAR was previously reported as a SAR relating to 33,333 shares of the Issuer's common stock at a base price of $14.00 and was adjusted as a result of the Dividend. In connection with the Dividend, all SARs held by the reporting person with respect to the Issuer's common stock were adjusted pursuant to the anti-dilution provisions of the incentive plan under which such award was granted, such that the number of shares subject to, and the base price of, such SAR were adjusted. These adjustments were approved by the compensation committee of the Issuer's board of directors pursuant to Rule 16b-3.
- [F13]This SAR was previously reported as a SAR relating to 66,667 shares of the Issuer's common stock at a base price of $14.10 and was adjusted as a result of the Dividend. In connection with the Dividend, all SARs held by the reporting person with respect to the Issuer's common stock were adjusted pursuant to the anti-dilution provisions of the incentive plan under which such award was granted, such that the number of shares subject to, and the base price of, such SAR were adjusted. These adjustments were approved by the compensation committee of the Issuer's board of directors pursuant to Rule 16b-3.
- [F14]This SAR was previously reported as a SAR relating to 16,573 shares of the Issuer's common stock at a base price of $14.00 and was adjusted as a result of the Dividend. In connection with the Dividend, all SARs held by the reporting person with respect to the Issuer's common stock were adjusted pursuant to the anti-dilution provisions of the incentive plan under which such award was granted, such that the number of shares subject to, and the base price of, such SAR were adjusted. These adjustments were approved by the compensation committee of the Issuer's board of directors pursuant to Rule 16b-3.
- [F15]This SAR was previously reported as a SAR relating to 33,146 shares of the Issuer's common stock at a base price of $14.10 and was adjusted as a result of the Dividend. In connection with the Dividend, all SARs held by the reporting person with respect to the Issuer's common stock were adjusted pursuant to the anti-dilution provisions of the incentive plan under which such award was granted, such that the number of shares subject to, and the base price of, such SAR were adjusted. These adjustments were approved by the compensation committee of the Issuer's board of directors pursuant to Rule 16b-3.
- [F16]This SAR was previously reported as a SAR relating to 25,445 shares of the Issuer's common stock at a base price of $9.69 and was adjusted as a result of the Dividend. In connection with the Dividend, all SARs held by the reporting person with respect to the Issuer's common stock were adjusted pursuant to the anti-dilution provisions of the incentive plan under which such award was granted, such that the number of shares subject to, and the base price of, such SAR were adjusted. These adjustments were approved by the compensation committee of the Issuer's board of directors pursuant to Rule 16b-3.
- [F17]This SAR was previously reported as a SAR relating to 50,890 shares of the Issuer's common stock at a base price of $9.63 and was adjusted as a result of the Dividend. In connection with the Dividend, all SARs held by the reporting person with respect to the Issuer's common stock were adjusted pursuant to the anti-dilution provisions of the incentive plan under which such award was granted, such that the number of shares subject to, and the base price of, such SAR were adjusted. These adjustments were approved by the compensation committee of the Issuer's board of directors pursuant to Rule 16b-3.
- [F18]This SAR was previously reported as a SAR relating to 16,522 shares of the Issuer's common stock at a base price of $7.81 and was adjusted as a result of the Dividend. In connection with the Dividend, all SARs held by the reporting person with respect to the Issuer's common stock were adjusted pursuant to the anti-dilution provisions of the incentive plan under which such award was granted, such that the number of shares subject to, and the base price of, such SAR were adjusted. These adjustments were approved by the compensation committee of the Issuer's board of directors pursuant to Rule 16b-3.
- [F19]This SAR was previously reported as a SAR relating to 33,044 shares of the Issuer's common stock at a base price of $7.78 and was adjusted as a result of the Dividend. In connection with the Dividend, all SARs held by the reporting person with respect to the Issuer's common stock were adjusted pursuant to the anti-dilution provisions of the incentive plan under which such award was granted, such that the number of shares subject to, and the base price of, such SAR were adjusted. These adjustments were approved by the compensation committee of the Issuer's board of directors pursuant to Rule 16b-3.
- [F2]As a result of the Dividend, the reporting person directly received 140 Preferred Shares in his IRA account.
- [F20]The SARs vest in full on March 15 2027.
- [F21]This SAR was previously reported as a SAR relating to 20,492 shares of the Issuer's common stock at a base price of $6.16 and was adjusted as a result of the Dividend. In connection with the Dividend, all SARs held by the reporting person with respect to the Issuer's common stock were adjusted pursuant to the anti-dilution provisions of the incentive plan under which such award was granted, such that the number of shares subject to, and the base price of, such SAR were adjusted. These adjustments were approved by the compensation committee of the Issuer's board of directors pursuant to Rule 16b-3.
- [F22]This SAR was previously reported as a SAR relating to 40,984 shares of the Issuer's common stock at a base price of $6.22 and was adjusted as a result of the Dividend. In connection with the Dividend, all SARs held by the reporting person with respect to the Issuer's common stock were adjusted pursuant to the anti-dilution provisions of the incentive plan under which such award was granted, such that the number of shares subject to, and the base price of, such SAR were adjusted. These adjustments were approved by the compensation committee of the Issuer's board of directors pursuant to Rule 16b-3.
- [F23]The SARs vest in two equal annual installments on March 15 of 2027 and 2028.
- [F24]This SAR was previously reported as a SAR relating to 18,939 shares of the Issuer's common stock at a base price of $6.69 and was adjusted as a result of the Dividend. In connection with the Dividend, all SARs held by the reporting person with respect to the Issuer's common stock were adjusted pursuant to the anti-dilution provisions of the incentive plan under which such award was granted, such that the number of shares subject to, and the base price of, such SAR were adjusted. These adjustments were approved by the compensation committee of the Issuer's board of directors pursuant to Rule 16b-3.
- [F25]This SAR was previously reported as a SAR relating to 37,879 shares of the Issuer's common stock at a base price of $6.66 and was adjusted as a result of the Dividend. In connection with the Dividend, all SARs held by the reporting person with respect to the Issuer's common stock were adjusted pursuant to the anti-dilution provisions of the incentive plan under which such award was granted, such that the number of shares subject to, and the base price of, such SAR were adjusted. These adjustments were approved by the compensation committee of the Issuer's board of directors pursuant to Rule 16b-3.
- [F26]The Share Appreciation Rights vest in three equal annual installments on March 15 of 2027, 2028 and 2029.
- [F27]This SAR was previously reported as a SAR relating to 16,768 shares of the Issuer's common stock at a base price of $7.58 and was adjusted as a result of the Dividend. In connection with the Dividend, all SARs held by the reporting person with respect to the Issuer's common stock were adjusted pursuant to the anti-dilution provisions of the incentive plan under which such award was granted, such that the number of shares subject to, and the base price of, such SAR were adjusted. These adjustments were approved by the compensation committee of the Issuer's board of directors pursuant to Rule 16b-3.
- [F28]This SAR was previously reported as a SAR relating to 33,536 shares of the Issuer's common stock at a base price of $7.77 and was adjusted as a result of the Dividend. In connection with the Dividend, all SARs held by the reporting person with respect to the Issuer's common stock were adjusted pursuant to the anti-dilution provisions of the incentive plan under which such award was granted, such that the number of shares subject to, and the base price of, such SAR were adjusted. These adjustments were approved by the compensation committee of the Issuer's board of directors pursuant to Rule 16b-3.
- [F3]Each Restricted Share Unit P ("RSU") represents a right to receive one share of the Issuer's Series A Preference Shares at settlement.
- [F4]The RSUs vest in full on March 15, 2027.
- [F5]The derivative security is fully vested.
- [F6]This share appreciation right award ("SAR") was previously reported as a SAR relating to 10,609 shares of the Issuer's common stock at a base price of $18.63 and was adjusted as a result of the Dividend. In connection with the Dividend, all SARs held by the reporting person with respect to the Issuer's common stock were adjusted pursuant to the anti-dilution provisions of the incentive plan under which such award was granted, such that the number of shares subject to, and the base price of, such SAR were adjusted. These adjustments were approved by the compensation committee of the Issuer's board of directors pursuant to Rule 16b-3.
- [F7]This SAR was previously reported as a SAR relating to 21,218 shares of the Issuer's common stock at a base price of $18.24 and was adjusted as a result of the Dividend. In connection with the Dividend, all SARs held by the reporting person with respect to the Issuer's common stock were adjusted pursuant to the anti-dilution provisions of the incentive plan under which such award was granted, such that the number of shares subject to, and the base price of, such SAR were adjusted. These adjustments were approved by the compensation committee of the Issuer's board of directors pursuant to Rule 16b-3.
- [F8]This SAR was previously reported as a SAR relating to 10,383 shares of the Issuer's common stock at a base price of $19.91 and was adjusted as a result of the Dividend. In connection with the Dividend, all SARs held by the reporting person with respect to the Issuer's common stock were adjusted pursuant to the anti-dilution provisions of the incentive plan under which such award was granted, such that the number of shares subject to, and the base price of, such SAR were adjusted. These adjustments were approved by the compensation committee of the Issuer's board of directors pursuant to Rule 16b-3.
- [F9]This SAR was previously reported as a SAR relating to 20,766 shares of the Issuer's common stock at a base price of $20.03 and was adjusted as a result of the Dividend. In connection with the Dividend, all SARs held by the reporting person with respect to the Issuer's common stock were adjusted pursuant to the anti-dilution provisions of the incentive plan under which such award was granted, such that the number of shares subject to, and the base price of, such SAR were adjusted. These adjustments were approved by the compensation committee of the Issuer's board of directors pursuant to Rule 16b-3.
Signature
/s/ John M. Winter, Attorney-in-Fact|2026-07-17